Jamie Stockton
Stock Analyst at Wells Fargo
(2.33)
# 2,462
Out of 4,784 analysts
22
Total ratings
46.67%
Success rate
10.81%
Average return
Main Sectors:
Stocks Rated by Jamie Stockton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Equal-Weight | $175 → $200 | $8.09 | +2,372.19% | 5 | Oct 29, 2020 | |
| OMCL Omnicell | Maintains: Equal-Weight | $74 → $84 | $35.01 | +139.93% | 2 | Oct 28, 2020 | |
| HQY HealthEquity | Maintains: Overweight | $63 → $70 | $86.96 | -19.50% | 6 | Sep 9, 2020 | |
| EVH Evolent Health | Maintains: Overweight | $19 → $17 | $9.60 | +77.08% | 2 | Jan 8, 2020 | |
| MMS Maximus | Maintains: Equal-Weight | $83 → $81 | $68.21 | +18.75% | 3 | Jan 8, 2020 | |
| IQV IQVIA Holdings | Maintains: Outperform | $140 → $160 | $177.39 | -9.80% | 2 | Feb 19, 2019 | |
| EHTH eHealth | Maintains: Market Perform | $18 → $24 | $6.58 | +264.74% | 2 | Oct 19, 2017 |
Teladoc Health
Oct 29, 2020
Maintains: Equal-Weight
Price Target: $175 → $200
Current: $8.09
Upside: +2,372.19%
Omnicell
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $74 → $84
Current: $35.01
Upside: +139.93%
HealthEquity
Sep 9, 2020
Maintains: Overweight
Price Target: $63 → $70
Current: $86.96
Upside: -19.50%
Evolent Health
Jan 8, 2020
Maintains: Overweight
Price Target: $19 → $17
Current: $9.60
Upside: +77.08%
Maximus
Jan 8, 2020
Maintains: Equal-Weight
Price Target: $83 → $81
Current: $68.21
Upside: +18.75%
IQVIA Holdings
Feb 19, 2019
Maintains: Outperform
Price Target: $140 → $160
Current: $177.39
Upside: -9.80%
eHealth
Oct 19, 2017
Maintains: Market Perform
Price Target: $18 → $24
Current: $6.58
Upside: +264.74%